AMDX2011P clinical trials
Also written AMDX-2011P.
How each study uses AMDX2011P is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the AMDX2011P studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- AMDX-2011P
- 4
Studies by the year they started
4 studies that test it; most in 2022 (1)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Amydis Inc. (4)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test AMDX2011P.
- Dec 2026A Study of AMDX-2011P in Participants With CAAPhase 2 · Amydis Inc.
- Jul 2027A Study of AMDX-2011P in Participants With Alzheimer's DiseasePhase 2 · Amydis Inc.
Studies
Open first, then newest update. How each study uses AMDX2011P is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Study of AMDX-2011P in Participants With Alzheimer's DiseaseRecruitingPhase 2Amydis Inc.NCT06514001Written as AMDX-2011P
- A Study of AMDX-2011P in Participants With CAARecruitingPhase 2Amydis Inc.NCT05709314Written as AMDX-2011P
- A Study of AMDX-2011P in Participants With Primary Open Angle GlaucomaRecruitingPhase 2Amydis Inc.NCT06223048Written as AMDX-2011P
- Study of AMDX-2011P as a Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic ProteinopathyCompletedPhase 1/2Amydis Inc.NCT05542576Written as AMDX2011P